FARALLON CAPITAL MANAGEMENT LLC - CONSTELLATION PHARMCETICLS I ownership

CONSTELLATION PHARMCETICLS I's ticker is CNST and the CUSIP is 210373106. A total of 136 filers reported holding CONSTELLATION PHARMCETICLS I in Q1 2021. The put-call ratio across all filers is 1.43 and the average weighting 0.7%.

Quarter-by-quarter ownership
FARALLON CAPITAL MANAGEMENT LLC ownership history of CONSTELLATION PHARMCETICLS I
ValueSharesWeighting
Q1 2021$23,390,000
+8.3%
1,000,000
+33.3%
0.12%
-10.8%
Q4 2020$21,600,000
+105.4%
750,000
+114.3%
0.13%
+54.8%
Q2 2020$10,518,000350,0000.08%
Other shareholders
CONSTELLATION PHARMCETICLS I shareholders Q1 2021
NameSharesValueWeighting ↓
TRV GP, LLC 3,034,083$37,259,00042.17%
Svennilson Peter 4,677,939$57,446,00016.42%
VHCP Management II, LLC 726,677$8,924,0002.81%
Casdin Capital, LLC 1,523,960$18,714,229,0001.75%
P.A.W. CAPITAL CORP 120,000$1,474,0001.59%
Cormorant Asset Management, LP 1,271,685$15,616,0000.90%
VHCP Management III, LLC 66,667$819,0000.38%
Orbimed Advisors 835,842$10,264,0000.16%
Hillhouse Capital Management 317,921$3,904,0000.12%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 183,600$2,255,0000.08%
View complete list of CONSTELLATION PHARMCETICLS I shareholders